7th French International Symposium
on CAR T Cells (CAR T Day)

September 6th, 7th and 8th, 2023

Organized by the Faculty of Medicine and Lille University Hospital.
Under the auspices of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), The Société Française de lutte contre les Cancers et les leucémies de l’Enfant et de l’adolescent (SFCE), The Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), The Intergroup Francophone du Myélome (IFM), and The Lymphoma Study Association (LYSA).

You can download the latest version of the program here

Wednesday September 6th, 2023

08:00 – Welcome and registration

09:45 – Introduction

Frédéric Boiron, General Director of Lille University Hospital TBC
Ibrahim Yakoub-Agha and Suman Mitra


Engineering the next-generation of CAR T-cells

Chairs: Ignacio Moraga (Dundee; Scotland) & chair(s) (city, country)

10:00 – Fighting fire with fire: Boosting T cell-based immunotherapies by mitochondrial transfer

Luca Gattinoni (Regensburg, Germany)

10:25 – Exploring Cell-Specific Viral Entry Approaches to improve gene and cellular immunotherapy

Name of presenter (city, country) TBC

10:50 – T cell genome editing to improve cellular immunotherapy

Sidi Chen (Yale, USA) TBC

11:15 – Immunogenic Targets for Immunotherapy

Johanna Olweus (Norway) TBC

11:40 – Biomarkers to inform CAR-T therapies

Joseph Melenhorst (Cleveland, USA)


12:00 – Coffee break


12:30 – 13:15

Keynote lecture

Chair(s): name(s) of chair(s) (city, country)

Marcela Maus (USA)


13:15 – Lunch break


Symposium Industrial I

Chair(s): name(s) of chair(s) (city, country)

14:00 – Title

Name of presenter (city, country)

14:30 – Title

Name of presenter (city, country)


Symposium Industrial II

Chair(s): name(s) of chair(s) (city, coutry)

15:00 – Title

Name of presenter (city, country)

15:30 – Title

Name of presenter (city, country)


16:00 – Coffee break


16:30

Special lecture : Pioneering the In Vivo Cell Engineering Approaches for cancer treatments

Chairs : Suman Mitra (Lille, France) & Ibrahim Yakoub-Agha (Lille, France)

Gill SAAR (Philadelphia, USA)


Session LYSA

Chair(s) : name(s) of chair(s) (city, country)

17:00 – Title

Name of presenter (city, country)

17:20 – Title

Name of presenter (city, country)

17:40 – Title

Name of presenter (city, coutry)


18:00 –  Closing remarks

Thursday September 7th, 2023

08:30 – Welcome and registration


Session IFM

Chair(s) : name(s) of chair(s) (city, country)

09:00 – CAR T cells in MM from clinical studies to real life: Where are we ?

Xavier Leleu (Poitiers, France)

09:20 – Relapse after anti BCMA CAR T cells: Outcome and mechanisms of resistance

Bertrand Arnulf (Paris, France)

09:40 – Future directions for cellular immunotherapy in MM

Salomon Manier (Lille, France)


10:00 – Coffee break

10:20 – Group photo


Symposium Industrial III

Chair(s) : name(s) of chair(s) (city, country)

10:30 – Title

Name of presenter (city, country)

11:00 – Title

Name of presenter (city, country)


11:30 – 12:15

Keynote lecture

Chairs : Erwan Mortier (Nantes, France) & Suman Mitra (Lille, France)

Warren J. Leonard


12:15 – Lunch


Session SFGM-TC: CAR T-cell toxicity and patient’s management

Chairs : Stéphanie Nguyen (Paris), Raynier Devillier (Marseille)

13:10 – Stem cell transplantation as a backbone for modern cell- and gene therapy

Stephan Mielke (Stockholm, Sweden)

13:30 – Immune effector hematotoxicity : European Guidelines

Marion Subklewe (München, Germany) TBC

13:50 – Place of Anakinra in ICANS

Jordan Gauthier (Seattle, USA) TBC

14:10 – Myeloid neoplasms following CAR T for lymphoid malignancies

Ibrahim Yakoub-Agha (Lille, France)


14:30 – Coffee break


Session CAR T beyond Leukemia and Lymphoma

Chairs: Geoffrey Guittard (Marseille, France) & Arnaud Scherpereel (Lille, France)

15:00 – Title

Name of presenter (city, country)

15:20 – CAR monocytes for cancer immunotherapy

Jean-Luc Perfettini (city, France)

15:40 – CAR-T cell therapy for Cardiac fibrosis

Name of presenter (city, country) TBC

16:00 – Personalized T-cell therapies for solid cancers

Alena Gros (city, Spain)


16:20 – Coffee break


Modulating the Tumor Microenvironment

Chairs : Christelle Harly (Nantes, France) & Emmanuel Donnadieu (Paris, France)

16:50 – Lymphoma Microenvironment

Karin Tarte (Rennes, France) TBC

17:10 – Metabolic barriers to cancer immunotherapy

Greg Delgoffe (Pittsburg, USA)

17:40 – ion channels in T-cell immunotherapy

Robert Eil (Oregon, USA)


18:00 – Closing remarks

20:00 – Gala dinner

Friday September 8th, 2023

08:30 – Welcome and registration


Session GRAALL & SFCE :

Chairs: Nicolas Boissel (Paris, France) & André Baruchel (Paris, France)

9:00 – New CAR T-cell development in T-ALL

Paul Maciocia (London, UK) TBC

9:20 – B-ALL: Are two targets better than one?

Ching-Hon Pui (Memphis, USA) TBC

9:40 – Title

Name of presenter (city, country)


Round table : point-of-care production

Chairs : Ibrahim Yakoub-Agha (Lille, France), Christian Chabannon (Marseille, France)

10:00 – Centralized production versus point-of-care production

Chrystel Marton (Lille, France)

10:10 – Difficulties and challenge for point-of-care production

Arnon Nagler (Tel Aviv, Israel)

10:20 – Round table

Olivier Boyer (Rouen, France), Jérôme Larghero (Paris, France), Camille Giverne (Rouen, France), Christophe Ferrand (Besançon, France), Arnon Nagler (Tel Aviv, Israel), Chrystel Marton (Lille, France).


11:00 – Coffee break


Symposium Industrial IV

Chair(s): name(s) of chair(s) (city, country)

11:30 – Title

Name of presenter (city, country)


Closing session

Chairs: Louis Terriou (Lille, France) & name of chair (city, country)

12:00 – Incorporating radiation with Car T-cell therapy

Omran Saifi (Florida, USA)

12:20 – Boosting antitumoral T cell responses with the epichaperome inhibitor PU-H71 : perspectives for CAR T cell and other cellular immunotherapies

Monica Guzman (NY, USA)

12:40 – Infections and CAR T

David Beauvais (Lille, France) TBC

13:00 – CAR-T cell therapy for Lupus

Georg Schett (city, Germany)


13:00 – Conclusion and end of the CARTday 2023 meeting